ADN Latest Quarter's Earnings
| Announce Date | 08/20/2024 |
| EPS Normalized Actual | $-10.32 (Miss by $-4.32) |
| EPS GAAP Actual | $-10.32 (Miss by $-4.32) |
| Revenue Actual | $9.9E-5B |
| Revenue Surprise | Beat by $0.099M |
Upcoming Quarter's Earnings
| Announce Date | 09/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.000101403B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 1.313 | 2.25 | 1.313 | 1.313 | 0 |
| Dec 2025 | 0.1 | 29.6 | 0.1 | 0.1 | 0 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -1.42 | -1.42 | 9.9E-5B | -713.13% | -0.04M |
| FQ1 2025 (Mar 2025) | -1.24 | -1.24 | 0.000132B | -2514.39% | 0.13M |
| FQ4 2024 (Dec 2024) | -0.699 | -0.699 | -0.000244B | 717.21% | -0.24M |
| FQ3 2024 (Sep 2024) | -7.03 | -8.57141 | 0.000128B | -887.5% | -2.37M |
| FQ1 2024 (Mar 2024) | -3.62 | -5.19645 | 0.003451B | 100% | 1.51M |
| FQ2 2024 (Jun 2024) | -4.28 | -5.62259 | 0.000805B | 100% | -1.42M |
| FQ4 2023 (Dec 2023) | -9.97 | -9.82 | 0.001506B | 100% | -0.16M |
| FQ4 2019 (Dec 2019) | -6.53 | -6.53 | 0.000227904B | 100% | 0.23M |
Quarterly Estimates Summary
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.000101403B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | INF | 0 | 0 | 0 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0B | -26.23 | 0B | 0B | 1 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
5
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0 | -1.42 | -1.42 | 100% |
| FQ1 2025 (Mar 2025) | -1.24 | -1.24 | 100% | |
| FQ4 2024 (Dec 2024) | -0.699 | -0.699 | 100% | |
| FQ3 2024 (Sep 2024) | 1.54141 | -7.03 | -8.57141 | 121.93% |
| FQ1 2024 (Mar 2024) | 1.57645 | -3.62 | -5.19645 | 143.55% |
| FQ2 2024 (Jun 2024) | 1.34259 | -4.28 | -5.62259 | 131.37% |
| FQ4 2023 (Dec 2023) | -0.15 | -9.97 | -9.82 | 98.5% |
| FQ4 2019 (Dec 2019) | -6.53 | -6.53 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0B | $-0.04M | -36.57% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0.13M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $-0B | $-0.24M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $-2.37M | -1854.69% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $1.51M | 43.61% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $-1.42M | -176.27% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $-0.16M | -10.76% |
| FQ4 2019 (Dec 2019) | $0B | $0B | $0.23M | 100% |
ADN Ratings Summary
ADN Quant Ranking
